Mark J. Bishton is a Hematologist-Oncologist based at St. Andrew's Place in East Melbourne, VIC 3002. He looks after people with blood cancers and other blood and immune related conditions, including lymphomas, leukaemias, and some related disorders that can affect the bone marrow.
In many cases, these illnesses can be complex and stressful for families. Mark focuses on listening first, then explaining what is happening in plain terms. He works with patients and their carers to map out next steps, including treatment options, what to expect along the way, and how to manage side effects.
His clinical work includes conditions such as mantle cell lymphoma, non-Hodgkin lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, Hodgkin lymphoma, and several types of T-cell lymphoma and B-cell lymphoma. He also sees people with chronic lymphocytic leukaemia, chronic B-cell leukaemia, small lymphocytic lymphoma, and Waldenstrom macroglobulinemia. For some patients, issues like low platelets (thrombocytopenia) and splenic-related blood conditions can also be part of the picture.
Mark also treats rarer conditions that involve immune cells and inflammation, including histiocytosis and related disorders. At times, care may include conditions linked to abnormal immune cell activity, as well as more serious infections that can involve the brain and other areas. When appropriate, his approach covers support through major treatments, including bone marrow transplant.
Over time, patients benefit from a steady, practical plan that balances the cancer side of care with overall wellbeing. Mark stays focused on the details that matter for real life, like keeping things clear, checking symptoms early, and adjusting the plan when things change.
Education is built around specialist haematology and oncology training, and his practice involves ongoing learning so treatment decisions reflect current best practice. Depending on the diagnosis and stage, he may discuss clinical trial options and newer approaches where they fit, aiming to make sure patients are aware of the choices available.
